Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock( )

AIMS: Soluble urokinase–type plasminogen activator receptor (suPAR) is a biomarker reflecting the level of immune activation. It has been shown to have prognostic value in acute coronary syndrome and heart failure as well as in critical illness. Considering the complex pathophysiology of cardiogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hongisto, Mari, Lassus, Johan, Tarvasmäki, Tuukka, Sans-Roselló, Jordi, Tolppanen, Heli, Kataja, Anu, Jäntti, Toni, Sabell, Tuija, Banaszewski, Marek, Silva-Cardoso, Jose, Parissis, John, Jurkko, Raija, Spinar, Jindrich, Castrén, Maaret, Mebazaa, Alexandre, Masip, Josep, Harjola, Veli-Pekka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Scientific Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629697/
https://www.ncbi.nlm.nih.gov/pubmed/35949144
http://dx.doi.org/10.1093/ehjacc/zuac096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629697/
https://www.ncbi.nlm.nih.gov/pubmed/35949144
http://dx.doi.org/10.1093/ehjacc/zuac096

Ejemplares similares